45 CFR § 180 compliance
B · 85
This hospital published most of what § 180 requires.
●Machine-readable file published
●Gross / standard charges
●Discounted cash price
●Payer-specific negotiated rates
○Min / max negotiated charges
●Free, public, no login required
Procedures listed
40,516
Insurances with rates
43
CPT / HCPCS codes
0
Source MRF
Most expensive procedures (gross)
| Code | Description | Gross | Cash | Min payer | Max payer | # insurers |
|---|---|---|---|---|---|---|
| RX-184296 | TISAGENLECLEUCEL 0.2 X10EXP6 TO 2.5X10EXP8 CELL INTRAVENOUS SUSPENSION | $3,561,200 | $1,602,540 | — | — | 4 |
| RX-194912 | LISOCABTAGENE MARALEUCEL(CD8) 1.5X TO 70X 10EXP6 CELL/ML IV SUSP(1OF2) | $3,347,508 | $1,506,378 | — | — | 5 |
| RX-194534 | LISOCABTAGENE MARALEUCEL 1.5 X 10EXP6 TO 70 X 10EXP6 CELL/ML IV SUSP | $3,347,508 | $1,506,378 | — | — | 5 |
| RX-194913 | LISOCABTAGENE MARALEUCEL(CD4) 1.5X TO 70X 10EXP6 CELL/ML IV SUSP(2OF2) | $3,347,478 | $1,506,365 | — | — | 5 |
| RX-197753 | CILTACABTAGENE AUTOLEUCEL 0.5 X 10EXP6 TO 1X 10EXP8 CELL IV SUSPENSION | $3,331,863 | $1,499,338 | — | — | 10 |
| RX-184711 | AXICABTAGENE CILOLEUCEL INTRAVENOUS SUSPENSION | $3,293,400 | $1,482,030 | — | — | 4 |
| RX-195392 | IDECABTAGENE VICLEUCEL 300 X 10EXP6 TO 510 X 10EXP6 CELL IV SUSPENSION | $3,264,971 | $1,469,237 | — | — | 15 |
| RX-196750 | BREXUCABTAGENE AUTOLEUCEL 1X 10EXP6 TO 1X 10EXP8 CELL IV SUSPENSION | $3,021,480 | $1,359,666 | — | — | 10 |
| RX-192830 | BREXUCABTAGENE AUTOLEUCEL 2X 10EXP6 TO 2X 10EXP8 CELL IV SUSPENSION | $3,021,480 | $1,359,666 | — | — | 10 |
| RX-186188 | TISAGENLECLEUCEL 0.6 X 10EXP8 TO 6 X10EXP8 CELL INTRAVENOUS SUSPENSION | $2,933,561 | $1,320,103 | — | — | 3 |
| RX-198777 | VUTRISIRAN 25 MG/0.5 ML SUBCUTANEOUS SYRINGE | $411,646 | $185,241 | — | — | 9 |
| RX-104852 | SIPULEUCEL-T IN LACTATED RINGERS 50 MILLION CELL/250 ML IV SUSPENSION | $270,441 | $121,699 | — | — | 6 |
| RX-172206 | HISTRELIN 50 MG (65 MCG/DAY) IMPLANT KIT | $178,270 | $80,222 | — | — | 26 |
| RX-192666 | INEBILIZUMAB-CDON 10 MG/ML INTRAVENOUS SOLUTION | $166,078 | $74,735 | — | — | 18 |
| RX-185623 | LUTETIUM LU 177 DOTATATE 10 MCI/ML (370 MBQ/ML) INTRAVENOUS SOLUTION | $165,335 | $74,401 | — | — | 10 |
| RX-207435 | OCRELIZUMAB 920 MG-HYALURONIDASE-OCSQ 23,000 UNIT/23 ML SUBCUT SOLN | $146,654 | $65,994 | — | — | 11 |
| RX-200750 | LENACAPAVIR 309 MG/ML SUBCUTANEOUS SOLUTION | $138,548 | $62,346 | — | — | 8 |
| PX-HS000648 | HC Lvad:Tci Heartmate | $131,796 | $59,308 | — | — | 2 |
| RX-108956 | IPILIMUMAB 200 MG/40 ML (5 MG/ML) INTRAVENOUS SOLUTION | $128,668 | $57,900 | — | — | 11 |
| RX-198045 | LUTETIUM LU-177 VIPIVOTIDE TETRAXETAN 27 MCI/ML (1,000 MBQ/ML) IV SOLN | $124,233 | $55,905 | — | — | 9 |
| RX-107664 | PEGLOTICASE 8 MG/ML INTRAVENOUS SOLUTION | $109,214 | $49,147 | — | — | 12 |
| SUP-1000100 | Impella 5.5 Smartassist S2 Set Us; MKOR: NONE, MPOR: C184000 | $102,096 | $45,943 | — | — | 3 |
| RX-195507 | LONCASTUXIMAB TESIRINE-LPYL 10 MG INTRAVENOUS SOLUTION | $100,613 | $45,276 | — | — | 9 |
| PX-81299999 | HC Kidney, Cadaver Donor | $94,523 | $42,535 | — | — | 3 |
| SUP-98142 | Tunneler Surg 2Mm Symm Vns Therapy Kit Model Vasc Strl Lf; MKOR: NONE, MPOR: NONE | $88,742 | $39,934 | — | — | 4 |
| SUP-1000 | Vns Sentiva Generator 1000; MKOR: NONE, MPOR: NONE | $86,645 | $38,990 | — | — | 4 |
| PX-HS000534 | HC Y-90 Ibritumomab Tiuxetan, per Tx. Dose (Zevalin) | $86,219 | $38,799 | — | — | 14 |
| RX-212817 | BELANTAMAB MAFODOTIN-BLMF 70 MG/1.4 ML IV (RECONSTITUTED VIAL) | $85,260 | $38,367 | — | — | 4 |
| RX-193811 | RAVULIZUMAB-CWVZ 100 MG/ML INTRAVENOUS SOLUTION | $85,086 | $38,289 | — | — | 20 |
| RX-184067 | INOTUZUMAB OZOGAMICIN 0.9 MG/3.6 ML IV (RECONSTITUTED VIAL) | $84,961 | $38,233 | — | — | 10 |
| RX-172883 | ALEMTUZUMAB 12 MG/1.2 ML INTRAVENOUS SOLUTION | $83,189 | $37,435 | — | — | 11 |
| RX-408400542 | PORFIMER IN DEXTROSE 5% WATER IV SYRINGE | $82,855 | $37,285 | — | — | 8 |
| RX-400542 | PORFIMER IN 0.9% SODIUM CHLORIDE IV SYRINGE | $82,855 | $37,285 | — | — | 9 |
| RX-14472 | PORFIMER SODIUM 75 MG/30 ML IV (RECONSTITUTED VIAL) | $82,855 | $37,285 | — | — | 6 |
| RX-184260 | TRIPTORELIN PAMOATE (PEDIATRIC) 22.5 MG IM SUSPENSION | $79,212 | $35,646 | — | — | 22 |
| PX-81199999 | HC Kidney; Living Donor | $77,921 | $35,064 | — | — | 4 |
| SUP-S3URCM20A | Valve Aortic 20Mm Sapien 3 Ultra Resilia Xenograft Transcath; MKOR: NONE, MPOR: NONE | $77,139 | $34,713 | — | — | 2 |
| SUP-S3URCM23A | Valve Aortic 23Mm Sapien 3 Ultra Resilia Xenograft Transcath; MKOR: NONE, MPOR: NONE | $77,139 | $34,713 | — | — | 2 |
| SUP-S3URCM26A | Valve Aortic 26Mm Sapien 3 Ultra Resilia Xenograft Transcath; MKOR: NONE, MPOR: NONE | $77,139 | $34,713 | — | — | 2 |
| SUP-S3URCM29A | Valve Aortic 29Mm Sapien 3 Ultra Resilia Xenograft Transcath; MKOR: NONE, MPOR: NONE | $77,139 | $34,713 | — | — | 2 |
| RX-195586 | RISANKIZUMAB-RZAA 150 MG/ML SUBCUTANEOUS PEN INJECTOR | $76,734 | $34,530 | — | — | 10 |
| RX-198787 | RISANKIZUMAB-RZAA 360 MG/2.4 ML (150 MG/ML) SUBCUT WEARABLE INJECTOR | $76,734 | $34,530 | — | — | 9 |
| PX-HS000152 | HC Tavr Heart Valve Kit | $76,125 | $34,256 | — | — | 4 |
| RX-182156 | CANAKINUMAB (PF) 150 MG/ML SUBCUTANEOUS SOLUTION | $75,968 | $34,186 | — | — | 9 |
| SUP-9600CT20A | KIT AORTIC VALVE @@@ Valve Heart 20Mm Certitude Transcatheter Aortic Stent-Like; MKOR: NONE, MPOR: N | $73,736 | $33,181 | — | — | 3 |
| SUP-9600CT23A | KIT AORTIC VALVE @@@ Kit Aor Vlv 18Fr Certitude; MKOR: NONE, MPOR: NONE | $73,736 | $33,181 | — | — | 3 |
| SUP-9600CT26A | KIT AORTIC VALVE @@@ Valve Heart 26Mm Certitude Transcatheter Aortic Stent-Like; MKOR: NONE, MPOR: N | $73,736 | $33,181 | — | — | 3 |
| SUP-9600CT29A | KIT AORTIC VALVE @@@ Valve Heart 29Mm Certitude Transcatheter Aortic Stent-Like; MKOR: NONE, MPOR: N | $73,736 | $33,181 | — | — | 3 |
| SUP-9600CM23A | KIT AORTIC VALVE COMMANDER * VLV AOR 23MM EDWRD SAPIEN 3 | $73,736 | $33,181 | — | — | 1 |
| SUP-9600CM26A | KIT AORTIC VALVE COMMANDER * VLV AOR 26MM EDWRD SAPIEN 3 | $73,736 | $33,181 | — | — | 1 |
Showing top 50 of 40,516 priced procedures, sorted by gross charge.
Data straight from this hospital's federally-mandated machine-readable file (45 CFR § 180). The compliance grade reflects how completely the hospital published the six required data elements, not the quality of care.